COVID-19 lockdown reduced childhood wheezing and bronchiolitis cases
Can't see this email? View it online
   
  Pulmonology Pulmonology logo  
  The latest pulmonology news from News Medical  
 Over-the-counter nasal sprays cut respiratory infections by 20%, study findsOver-the-counter nasal sprays cut respiratory infections by 20%, study finds
 
Widely available over-the counter nasal sprays could keep upper respiratory tract infections - like colds, chest infections, flu, sore throat, and sinus infections - at bay, and prevent full-blown symptoms from developing, one of the largest trials to date to test their effectiveness finds.
 
 
 COVID-19 lockdown reduced childhood wheezing and bronchiolitis casesCOVID-19 lockdown reduced childhood wheezing and bronchiolitis cases
 
Bronchiolitis cases dropped significantly during the COVID-19 lockdown, leading to fewer wheezing episodes and reduced respiratory medication use in children.
 
   40% of US cancer cases linked to lifestyle choices40% of US cancer cases linked to lifestyle choices
 
Nearly 40% of cancer cases and 44% of cancer deaths in 2019 were due to modifiable risk factors, with cigarette smoking as the leading cause. This study highlights the potential to significantly reduce cancer burden through lifestyle changes.
 
   AI model accurately estimates pulmonary function from chest x-raysAI model accurately estimates pulmonary function from chest x-rays
 
Chest x-rays using a deep learning-based model.
 
   Novel device uses a simple blood test to detect early stage lung cancerNovel device uses a simple blood test to detect early stage lung cancer
 
University of Queensland researchers have designed a device that uses a simple blood test to detect early stage lung cancer.
 
 One-time prime editing targets common genetic cause of cystic fibrosis
 
One-time prime editing targets common genetic cause of cystic fibrosisResearchers optimized prime editing for the efficient correction of the cystic fibrosis transmembrane conductance regulator F508del mutation in human airway epithelial cells, achieving high correction efficiencies and functional restoration with minimal off-target effects.
 
 
 New consortium receives NIH grant to accelerate development of effective TB treatments
 
New consortium receives NIH grant to accelerate development of effective TB treatmentsA new consortium co-led by Weill Cornell Medicine, has been awarded a five-year, $31 million grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases to accelerate the development of faster, more effective treatment regimens for tuberculosis (TB).
 
 
 UQ study offers insights into how Haemophilus influenzae manipulates the immune system
 
UQ study offers insights into how Haemophilus influenzae manipulates the immune systemResearchers from The University of Queensland have identified how a common bacterium is able to manipulate the human immune system during respiratory infections and cause persistent illness.
 
 
 Discovery of "unconventional" immune response opens new avenue in TB vaccine development
 
Discovery of "unconventional" immune response opens new avenue in TB vaccine developmentAn "unconventional" immune response now identified by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) is a potential new pathway for developing new vaccines for tuberculosis (TB), according to a new publication.
 
 
 Early antibiotic exposure can trigger long term susceptibility to asthma
 
Early antibiotic exposure can trigger long term susceptibility to asthmaEarly exposure to antibiotics can trigger long term susceptibility to asthma, according to new research from Monash University.